SAGE® Labs Licenses CRISPR/Cas9 Technology from the Broad Institute

ST. LOUIS -- SAGE Labs Inc., a leading provider of products, services and technologies in the field of genome engineering, announced today that they have licensed CRISPR/Cas9 technology from the Broad Institute. The license enables SAGE Labs to use the CRISPR/Cas9 system to engineer cell and animal models for their clients as well as distribute [...]

NanoString Technologies Introduces New Universal Junction Probe Design for Detecting Gene Fusions

SEATTLE & CHICAGO -- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that it has expanded the capabilities of its nCounter Elements™ General Purpose Reagents (GPRs) with the addition of a universal junction probe design that offers specific detection and analysis of known fusion [...]

Cellectis sells its Swedish subsidiary, Cellectis AB, to the Japanese company Takara Bio Inc.

Paris, France — Cellectis (Alternext: ALCLS.PA), a leader in the development of adoptive immunotherapies based on engineered allogeneic CART cells (UCART) announces today the sale of its subsidiary Cellectis AB to the Japanese Company Takara Bio Inc. This operation, which will be realized in the coming weeks subject to the completion of certain usual conditions, [...]

Phenomenex Launches Phenova® Certified Reference Materials for Environmental Laboratories

Torrance, CA -– Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for separation sciences, announces the addition of Phenova Certified Reference Materials (CRMs) – a comprehensive line of ISO/IEC 17025- and ISO Guide 34-compliant standards for the calibration of analytical equipment and quantitation of analytical measurements for environmental testing. Sold [...]

Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies

NEW YORK, NY -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life Science’s U.S. Patents Nos. 6,992,180, 7,064,197, and 8,097,405. The hearing will be held in Delaware District [...]

23andMe Scientists Receive Approximately $1.4 Million in Funding from the National Institutes of Health

MOUNTAIN VIEW, CA –– 23andMe, the leading personal genetics company, has received from the National Institutes of Health (NIH) a grant totaling $1,367,504 for a two-year project to support the further development of 23andMe’s web-based database and research engine for genetic discovery. Specifically, the grant supports four areas of development: •Refinement of web-based surveys to [...]

KPL Expands BacTrace® Line

Milford, Massachusetts -- KPL, a SeraCare Company, today announced the addition of three new products to its growing line of BacTrace antibodies: BacTrace® Antibody Coated Latex Beads, BacTrace® STEC Antibodies, and BacTrace® Salmonella CSA-Plus Antibodies. These tools are designed for use by researchers and developers of foodborne pathogen assays. As polyclonals, the BacTrace antibodies can [...]

FEI Adds Phase Plate Technology and Titan Halo TEM to Its Structural Biology Product Portfolio

HILLSBORO, Ore.-- FEI (Nasdaq:FEIC) announced two new products for cryo-electron microscopy applications: a new phase plate solution and the Titan Halo™ transmission electron microscope (TEM). The phase plate is a stable, durable solution to increase the contrast of sensitive biological samples and is available on most TEM platforms from FEI. The Titan Halo TEM provides [...]

Bruker Announces Acquisition of High-Speed, 3D Super-Resolution Fluorescence Microscopy Company Vutara

BILLERICA, Mass.-- Bruker (NASDAQ:BRKR) today announced that it has acquired Vutara Incorporated, a technology leader in high-speed, three-dimensional (3D), super-resolution fluorescence microscopy for life science applications. Transaction details were not disclosed. Vutara’s estimated revenue for the full year 2014 is expected to be approximately $2 million. The acquisition further strengthens Bruker’s biological microscopy business by [...]

INTEGRA PIpette Streamlines Screening of Novel Protein Therapeutics

Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins. DARPins are a next generation of protein therapeutics combining the advantages of antibodies and small molecule drugs. High target specificity [...]

Access IBO on Knowledge Center